BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32545852)

  • 1. Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo.
    Nešović M; Divac Rankov A; Podolski-Renić A; Nikolić I; Tasić G; Mancini A; Schenone S; Pešić M; Dinić J
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line.
    Cammarata FP; Torrisi F; Forte GI; Minafra L; Bravatà V; Pisciotta P; Savoca G; Calvaruso M; Petringa G; Cirrone GAP; Fallacara AL; Maccari L; Botta M; Schenone S; Parenti R; Cuttone G; Russo G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
    Vagaggini C; Petroni D; D'Agostino I; Poggialini F; Cavallini C; Cianciusi A; Salis A; D'Antona L; Francesconi V; Manetti F; Damonte G; Musumeci F; Menichetti L; Dreassi E; Carbone A; Schenone S
    Drug Dev Res; 2024 Feb; 85(1):e22158. PubMed ID: 38349262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells.
    Baillache DJ; Valero T; Lorente-Macías Á; Bennett DJ; Elliott RJR; Carragher NO; Unciti-Broceta A
    RSC Med Chem; 2023 Dec; 14(12):2611-2624. PubMed ID: 38099057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance.
    Torrisi F; Vicario N; Spitale FM; Cammarata FP; Minafra L; Salvatorelli L; Russo G; Cuttone G; Valable S; Gulino R; Magro G; Parenti R
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33020459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteomic approach supports the clinical relevance of TAT-Cx43
    Pelaz SG; Flores-Hernández R; Vujic T; Schvartz D; Álvarez-Vázquez A; Ding Y; García-Vicente L; Belloso A; Talaverón R; Sánchez JC; Tabernero A
    Transl Res; 2024 Jun; 272():95-110. PubMed ID: 38876188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction: Developing and Testing Methylated Nano-Structured Dipeptides that Inhibit Src Kinase Activity In Vitro for Anti-Cancer Applications.
    J Vis Exp; 2023 Dec; (202):. PubMed ID: 38096042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy of human leukemia xenografts in immunodeficient zebrafish.
    Somasagara RR; Huang X; Xu C; Haider J; Serody JS; Armistead PM; Leung T
    Sci Rep; 2021 Mar; 11(1):5715. PubMed ID: 33707624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo.
    Alburquerque-González B; Bernabé-García Á; Bernabé-García M; Ruiz-Sanz J; López-Calderón FF; Gonnelli L; Banci L; Peña-García J; Luque I; Nicolás FJ; Cayuela-Fuentes ML; Luchinat E; Pérez-Sánchez H; Montoro-García S; Conesa-Zamora P
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation.
    Iscan E; Ekin U; Yildiz G; Oz O; Keles U; Suner A; Cakan-Akdogan G; Ozhan G; Nekulova M; Vojtesek B; Uzuner H; Karakülah G; Alotaibi H; Ozturk M
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma.
    Cheung BB; Kleynhans A; Mittra R; Kim PY; Holien JK; Nagy Z; Ciampa OC; Seneviratne JA; Mayoh C; Raipuria M; Gadde S; Massudi H; Wong IPL; Tan O; Gong A; Suryano A; Diakiw SM; Liu B; Arndt GM; Liu T; Kumar N; Sangfelt O; Zhu S; Norris MD; Haber M; Carter DR; Parker MW; Marshall GM
    Oncogene; 2021 Apr; 40(13):2367-2381. PubMed ID: 33658627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of Zebrafish Xenograft Models in Cancer Research.
    Chen X; Li Y; Yao T; Jia R
    Front Cell Dev Biol; 2021; 9():616551. PubMed ID: 33644052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM83H-AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma.
    Wang S; Han C; Liu T; Ma Z; Qiu M; Wang J; You Q; Zheng X; Xu W; Xia W; Xu Y; Hu J; Xu L; Yin R
    Clin Transl Med; 2021 Feb; 11(2):e316. PubMed ID: 33634993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune evasion revealed in a colorectal zebrafish xenograft model.
    Póvoa V; Rebelo de Almeida C; Maia-Gil M; Sobral D; Domingues M; Martinez-Lopez M; de Almeida Fuzeta M; Silva C; Grosso AR; Fior R
    Nat Commun; 2021 Feb; 12(1):1156. PubMed ID: 33608544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling Tumor Microenvironment Interactions Using Zebrafish Models.
    Loveless R; Shay C; Teng Y
    Front Mol Biosci; 2020; 7():611847. PubMed ID: 33521055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small extracellular vesicles deliver TGF-β1 and promote adriamycin resistance in breast cancer cells.
    Tan C; Sun W; Xu Z; Zhu S; Hu W; Wang X; Zhang Y; Zhang G; Wang Z; Xu Y; Tang J
    Mol Oncol; 2021 May; 15(5):1528-1542. PubMed ID: 33508878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance.
    Al-Akhrass H; Conway JRW; Poulsen ASA; Paatero I; Kaivola J; Padzik A; Andersen OM; Ivaska J
    Oncogene; 2021 Feb; 40(7):1300-1317. PubMed ID: 33420373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small extracellular vesicle-mediated Hsp70 intercellular delivery enhances breast cancer adriamycin resistance.
    Hu W; Xu Z; Zhu S; Sun W; Wang X; Tan C; Zhang Y; Zhang G; Xu Y; Tang J
    Free Radic Biol Med; 2021 Feb; 164():85-95. PubMed ID: 33418113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature.
    El-Sahli S; Hua K; Sulaiman A; Chambers J; Li L; Farah E; McGarry S; Liu D; Zheng P; Lee SH; Cui J; Ekker M; Côté M; Alain T; Li X; D'Costa VM; Wang L; Gadde S
    Cell Death Dis; 2021 Jan; 12(1):8. PubMed ID: 33414428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of focal Wnt activity via synthetic cells in a double-humanized zebrafish model of tumorigenesis.
    Wang L; Long J; Chen H; Sun S; Lv K; Li Q; Wang X
    Int J Cancer; 2021 Jun; 148(11):2815-2824. PubMed ID: 33368276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.